| Literature DB >> 28570702 |
Matias Ekstrand1, Emma Widell1, Anna Hammar1, Levent M Akyürek2, Martin Johansson3, Björn Fagerberg1, Göran Bergström1, Malin C Levin1, Per Fogelstrand1, Jan Borén1, Max Levin1,4.
Abstract
OBJECTIVE: Severe hypoxia develops close to the necrotic core of advanced human atherosclerotic plaques, but the energy metabolic consequences of this hypoxia are not known. In animal models, plaque hypoxia is also associated with depletion of glucose and ATP. ATP depletion may impair healing of plaques and promote necrotic core expansion. To investigate if ATP depletion is present in human plaques, we analyzed the distribution of energy metabolites (ATP, glucose, glycogen and lactate) in intermediate and advanced human plaques. APPROACH ANDEntities:
Mesh:
Substances:
Year: 2017 PMID: 28570702 PMCID: PMC5453577 DOI: 10.1371/journal.pone.0178877
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient characteristics (n = 6).
| Patient characteristics | |
|---|---|
| Age, years | 64.4 (58–81) |
| Male | 4 (67%) |
| Female | 2 (33%) |
| Amaurosis fugax | 3 (50%) |
| Stroke | 3 (50%) |
| Time from last clinical event to surgery (days) | 22.8 (9–40) |
| Diabetes | 5 (50%) |
| Hypertension | 5 (83%) |
| Smoking | 1 (17%) |
| HDL, mmol/L | 0.88 ± 0.29 |
| LDL, mmol/L | 2.21 ± 0.74 |
| Statins | 6 (100%) |
| Diuretics | 2 (33%) |
| ACE-I or ARB | 3 (50%) |
| Beta blocker | 2 (33%) |
| Calcium antagonist | 3 (50%) |
| Anti-platelet | 5 (83%) |
| Oral anti-diabetics | 3 (50%) |
| Insulin | 2 (33%) |
ACE-I = angiotensin converting enzyme inhibitor
ARB = angiotensin receptor blocker
HDL = high-density lipoprotein
LDL = low-density lipoprotein
a Continuous data are presented as mean (range low-high) or mean (± SD) and categorical data as number (%).
b n = 4; information on blood samples could not be obtained for all patients.
Fig 1Plaques were intermediate in common carotid artery (CCA) and advanced in internal carotid artery (ICA).
A. Plaques were obtained from CCA and ICA of human endarterectomies. Plaques in CCA were intermediate and plaques in ICA were advanced. B, C and D. Advanced plaques where thicker (B) and had higher macrophage content than intermediate plaques (C). There was no significant difference in smooth muscle cell content (C) or cellularity (D). Necrotic areas were larger in advanced plaques (D). n = 6, t-test (B) or Wilcoxon Signed-Rank Test (C and D).
Fig 2Depletion of ATP, glucose and glycogen in advanced human plaques.
A. Energy metabolites were analyzed in intermediate (CCA) and advanced (ICA) segments of human endarterectomies. B. Metabolite concentrations were assessed in the viable part of the intima (delineated), i.e. intimal area minus necrotic core. C, D and E. ATP (C), glucose (D) and glycogen concentrations (E) were lower in advanced segments than in intermediate segments of the same plaque. Note logarithmic scale for ATP and glycogen. F. Lactate concentrations were higher in advanced segments of the plaque. n = 6, Wilcoxon Signed-Rank Test.
Fig 3Severe depletion of ATP and glucose in perinecrotic zone of advanced plaques.
A. Advanced atherosclerotic plaque, delineation in white of viable intima. Extract shows luminal (left) and perinecrotic zone (right) of viable intima. Note high expression of hexokinase II (HKII), indicative of hypoxia, in perinecrotic zone. B and C. Lower concentrations of ATP (B) and glucose (C) in perinecrotic zone (p<0.05). D and E. No significant difference in glycogen (D) and lactate concentrations (E) between luminal and perinecrotic zone. n = 6, paired t-test.